Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient. (2019)

• Record Type: Journal Article
• Authors: Vargas, Maria; Buonomo, Antonio Riccardo; Buonanno, Pasquale; Iacovazzo, Carmine; Servillo, Giuseppe
• Is Part Of: IDCases. Volume 18(2019)
• Publication Date: 2019
• Subjects: Ceftazidime-avibactam -- Septic shock -- Pediatric critically ill patient; Communicable diseases -- Periodicals; Communicable Diseases -- Case Reports; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1016/j.idcr.2019.e00634
• Languages: English
• ISSNs: 2214-2509

Abstract

Abstract: Ceftazidime–avibactam is a combination agent consisting of the β-lactamase inhibitor avibactam and the broad-spectrum cephalosporin ceftazidime. There are no published case reports or studies evaluating the use of CAZ-AVI in pediatric critically ill patients. We report a case of a successful treatment of septic shock due to Klebsiella pneumonie (KP) in a 14-years-old boy (body weight 50 kg) admitted in intensive care unit (ICU).